FCM
Farallon Capital Management’s Revolution Medicines RVMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527M | Buy |
14,325,692
+791,000
| +6% | +$29.1M | 2.27% | 15 |
|
|
2025
Q1 | $479M | Buy |
13,534,692
+286,000
| +2% | +$10.1M | 2.37% | 15 |
|
|
2024
Q4 | $579M | Buy |
13,248,692
+1,931,000
| +17% | +$84.5M | 2.59% | 10 |
|
|
2024
Q3 | $513M | Buy |
11,317,692
+1,560,000
| +16% | +$70.7M | 2.27% | 11 |
|
|
2024
Q2 | $379M | Buy |
9,757,692
+2,249,820
| +30% | +$87.3M | 1.63% | 16 |
|
|
2024
Q1 | $242M | Buy |
7,507,872
+771,018
| +11% | +$24.8M | 1.03% | 27 |
|
|
2023
Q4 | $193M | Buy |
6,736,854
+3,411,374
| +103% | +$97.8M | 0.89% | 33 |
|
|
2023
Q3 | $92M | Buy |
3,325,480
+542,000
| +19% | +$15M | 0.43% | 42 |
|
|
2023
Q2 | $74.5M | Sell |
2,783,480
-500,120
| -15% | -$13.4M | 0.37% | 52 |
|
|
2023
Q1 | $71.1M | Buy |
3,283,600
+1,585,585
| +93% | +$34.3M | 0.39% | 52 |
|
|
2022
Q4 | $40.4M | Sell |
1,698,015
-801,985
| -32% | -$19.1M | 0.24% | 65 |
|
|
2022
Q3 | $49.3M | Sell |
2,500,000
-750,000
| -23% | -$14.8M | 0.27% | 69 |
|
|
2022
Q2 | $63.3M | Hold |
3,250,000
| – | – | 0.34% | 64 |
|
|
2022
Q1 | $82.9M | Buy |
3,250,000
+500,000
| +18% | +$12.8M | 0.4% | 53 |
|
|
2021
Q4 | $69.2M | Hold |
2,750,000
| – | – | 0.35% | 55 |
|
|
2021
Q3 | $75.7M | Buy |
2,750,000
+250,000
| +10% | +$6.88M | 0.35% | 58 |
|
|
2021
Q2 | $79.4M | Buy |
2,500,000
+890,270
| +55% | +$28.3M | 0.32% | 56 |
|
|
2021
Q1 | $73.9M | Buy |
+1,609,730
| New | +$73.9M | 0.37% | 58 |
|
|
2020
Q2 | – | Sell |
-20,733
| Closed | -$454K | – | 122 |
|
|
2020
Q1 | $454K | Buy |
+20,733
| New | +$454K | ﹤0.01% | 97 |
|